In-vitro transcutaneous delivery of tamoxifen and γ-linolenic acid from borage oil containing ethanol and 1,8-cineole

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 11, 2004, Pages 1357-1364

  Ho, Suzanna ^a   Calder, Richard J ^a   Thomas, Christopher P ^a   Heard, Charles M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BORAGE OIL; CINEOLE; GAMMA LINOLENIC ACID; PLANT EXTRACT; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER THERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFUSION; DOSE TIME EFFECT RELATION; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; FULL THICKNESS SKIN GRAFT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NONHUMAN; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTIRHEUMATIC AGENTS; CYCLOHEXANOLS; DRUG DELIVERY SYSTEMS; ETHANOL; GAMMA-LINOLENIC ACID; MONOTERPENES; PLANT OILS; SKIN; SOLVENTS; SWINE; TAMOXIFEN;

EID: 8144221909     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357044599     Document Type: Article

References (37)

1. Babu, R. J., Kanikkannan, N., Kikwai, L., Ortega, C., Andega, S., Ball, K., Yim, S., Singh, M. (2003) The influence of various methods of cold storage of skin on the permeation of melatonin and nimesulide. J. Control. Release 86: 49-57
2. Banning, T. P., Heard, C. M. (2002) Binding of doxycycline to keratin, melanin and human epidermal tissue. Int. J. Pharm. 235: 219-227
3. Begin, M. E., Ells, G., Horrobin, D. F. (1988) Polyunsaturated fatty acid-induced cytotoxicity against tumour cells and its relationship to lipid peroxidation. J. Natl Cancer Inst. 80: 188-194
4. Bhatia, K. S., Singh, J. (1999) Effect of linolenic acid/ethanol or limonene/ethanol and iontophoresis on the in vitro percutaneous absorption of LHRH and ultrastructure of human epidermis. Int. J. Pharm. 180: 235-250
5. Cai, J., Jiang, W. G., Mansel, R. E. (1999) Inhibition of angiogenic factor- and tumour-induced angiogenesis by gamma linolenic acid. Prostaglandins Leukot. Essent. Fatty Acids 60: 21-29
6. Curtis, C. L., Hughes, C. E., Flannery, C. R., Little, C. B., Harwood, J. L., Caterson, B. (2000) n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J. Biol. Chem. 275: 721-724
7. Cuzick, J., Powles, T., Veronesi, U., Forbes, J., Edwards, R., Ashley, S., Boyle, P. (2003) Overview of the main outcomes in breast-cancer prevention trials. Lancet 361: 296-300
8. Davies, R., Oreffo, V. I. C., Martin, E. A., Festing, M. F. W., White, I. N. H., Smith, L. L., Styles, J. A. (1997) Tamoxifen causes gene mutations in the livers of lambda/lacI transgenic rats. Cancer Res. 57: 1288-1293
9. Decensi, A., Robertson, C., Viale, G., Pigatto, F., Johansson, H., Kisanga, E. R., Veronesi, P., Torrisi, R., Cazzaniga, M., Mora, S., Sandri, M. T., Pelosi, G., Luini, A., Goldhirsch, A., Lien, E. A., Veronesi, U. (2003) A randomized trial of low dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers. J. Natl Cancer Inst. 95: 779-790
10. El-Kattan, A. F. (2001) The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int. J. Pharm. 215: 229-240
11. Fabian, C., Sternson, L., El Serafi, M. (1981) Clinical pharmacology of tamoxifen in patients with breast cancer: correlation with clinical data. Cancer 48: 876-882
12. Furr, B. J. A., Jordan, V. C. (1984) The pharmacology and clinical uses of tamoxifen. Pharmacol. Ther. 25: 127-205
13. Han, X., Liehr, J. G. (1992) Induction of covalent DNA adducts in rodents by tamoxifen, Cancer Res. 52: 1360-1363
14. Heard, C. M., Harwood, J., Maguire, P., McNaughton, G., Pugh, W. J. (2002) Simultaneous penetration of NSAID and essential fatty acid esters as a dual-action anti-arthritis therapy. In: Brain, K. R., Walters, K. A. (eds) Perspectives in percutaneous penetration. Vol 8a, STS Publishing, Cardiff, p. 93
15. Heard, C. M., Monk, B. V., Modley, A. J. (2003a) Binding of primaquine to epidermal membranes and keratin, Int. J. Pharm. 257: 237-244
16. Heard, C. M., Gallagher, S. J., Harwood, J. L., Maguire, P. B. (2003b) The in vitro delivery of NSAIDs across skin was in proportion to the delivery of essential fatty acids in the vehicle - evidence that solutes permeate skin associated with their solvation cages? Int. J. Pharm. 261: 165-169
17. Hori, M., Satoh, S., Maibach, H. I., Guy, R. H. (1991) Enhancement of propanolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity. J. Pharm. Sci. 80: 32-35
18. Jiang, W. G., Bryce, R. P., Horrobin, D. F. (1998a) Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. Crit. Rev. Oncol. Haematol. 27: 179-209
19. Jiang, W. G., Bryce, R. P., Horrobin, D. F., Mansel, R. E. (1998b) Regulation of tight junction permeability and occluding expression by polyunsaturated fatty acids. Biochem. Biophys. Res. Commun. 224: 414-420
20. Johnson, M. M. Swann, D. D. Surette, M. E. (1997) Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J. Nutr. 127: 1435-1444
21. Karia, C., Harwood, J. L., Heard, C. M., Morris, A. P. (2004) Simultaneous permeation of tamoxifen and γ linolenic acid across excised human skin. Int. J. Pharm, 271: 305-309
22. Kenny, F. S., Pinder, S. E., Ellis, I. O., Gee, J. M. W., Nicholson, R. I., Bryce, R. P., Robertson, J. F. R. (2000) Gamma linolenic acid with tamoxifen as primary therapy in breast cancer. Int. J. Cancer 85: 643-648
23. Kenny, F. S., Gee, J. M. W., Nicholson, R. I., Ellis, I. O., Morris, T. M., Watson, S. A., Bryce, R. P., Robertson, J. F. R. (2001) Effect of dietary GLA +/- tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenografts. Int. J. Cancer 92: 342-347
24. Levison, K. K., Takayama, K., Isowa, K., Okabe, K., Nagai, T. (1994) Formulation optimization of indomethacin gels containing a combination of three kinds of cyclic monoterpenes as percutaneous penetration enhancers. J. Pharm. Sci. 83: 1367-1372
25. Lin, J. T., McKeon, T. A., Stafford, A. E. (1995) Gradient reversed phase HPLC of saturated, unsaturated and oxygenated free fatty acids and their methyl esters. J. Chromatogr. A 699: 85-91
26. Meyer, W., Zschemisch, N. H., Godynicki, S., Neurand, K. (2001) Investigations in the structure of the ear in the domesticated pig, with special reference to the use for human dermatological research: 2. Specific histology of the integument. Berl. Munch. Tierarztl. Wochenschr. 114: 3-4, 100-111
27. Naidu, M. R. C., Das, U. N., Kishan, A. (1992) Intratumoral gamma-linoleic acid therapy of human gliomas. Prostaglandins Leukot. Essent. Fatty Acids 45: 181-184
28. Patterson, J. S., Settatree, R. S., Adam, H. K., Kemp, J. V. (1980) Serum concentrations of tamoxifen and major metabolite during long-term 'Nolvadex' therapy correlated with clinical response. Eur. J. Cancer Suppl. 1: 89-92
29. Pujol, H., Girault, J., Rouanet, P., Fournier, S., Grenier, J., Simony, J., Fourtillan, J. B., Pujol, J. L. (1995) Phase I study of percutaneous 4-hydroxytamoxifen with analyses of 4-hydroxytamoxifen concentrations in breast cancer and normal breast tissue. Cancer Chemother. Pharmacol. 36: 493-498
30. Rose, D. P., Connolly, J. M. (1999) Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol. Ther. 83: 217-244
31. Simon, G. A., Maibach, H. I. (2000) The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations - an overview. Skin Pharmacol. Appl. Skin Physiol. 13: 229-234
32. Tapiero, H., Ba, G. N., Couvreur, P., Tew, K. D. (2002) Polyunsaturated fatty acids and eicosanoids in human health and pathologies. Biomed. Pharmacother. 56: 215-222
33. Valiveti, S., Hammell, D. C., Earles, D. C., Stinchcomb, A. L. (2004) In vitro/in vivo correlation studies for transdermal Delta(8)-THC development. J. Pharm. Sci. 93: 1154-1164
34. Williams, A. C. (2003) Transdermal and topical drug delivery. Pharmaceutical Press, London, UK, pp 83-122
35. Wynder, E. L. Rose, D. P. Cohen, L. A. (1986) Diet and breast cancer in causation and therapy. Cancer 58: 1804-1813
36. Xiong, G. L., Quan, D. Y., Maibach, H. I. (1996) Effects of penetration enhancers on in vitro percutaneous absorption of low molecular weight heparin through human skin. J. Control. Release 42: 289-296
37. Yamane, M. A., Williams, A. C., Barry, B. W. (1995) Effects of terpenes and oleic acid as skin penetration enhancers towards 5-fluorouracil as assessed with time- permeation, partitioning and differential scanning calorimetry. Int. J. Pharm. 116: 237-251